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Abstract 
Biological toxicity of E. coli heat-labile nterotoxin and the closely related cholera toxin requires that the assembled toxin be activated by proteolytic 
cleavage of the A subunit and reduction of a disulfide bond internal to the A subunit. The structural role served by this reduction and cleavage is 
not known, however. We have crystallographically determined the structure of the E. coli heat-labile nterotoxin AB, hexamer in which the A subunit 
has been cleaved by trypsin between residues 192 and 195. The toxin is thus partially activated, in that it has been cleaved but the disulfide bond 
has not been reduced. The structure of the A subunit in the cleaved toxin is substantially the same as that previously observed for the uncleaved 
AB, structure, suggesting that although such cleavage is required for biological activity of the toxin it does not by itself cause a conformational change. 
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1. Introduction 
The heat-labile nterotoxin (LT) from E. coli is a mem- 
ber of a class of medically important bacterial toxins 
which act intracellularly to catalyze ADP-ribosylation of 
specific cell proteins. These toxins share an A/B func- 
tional organization in which the B fragment mediates 
specific binding to cell surface receptors while the A 
fragment contains the enzymatic activity. In the case of 
LT and the 80% sequence-identical cholera toxin (CT), 
the holotoxin forms an ABS hexamer. In both LT and CT 
a pentamer of identical B subunits binds specifically to 
the terminal oligosaccharide of ganglioside GM1 protrud- 
ing from the intestinal epithelial cell membrane. In both 
toxins toxicity is due to catalytic activity of the A subunit 
in the cytosol of the target cell, where it causes ADP- 
ribosylation of the a subunit of the G, regulatory pro- 
tein. Both LT and CT cause diarrhea1 disease and dehy- 
dration, although the severity of the disease caused by 
enterotoxigenic E. coli is much less than that of cholera. 
We have previously reported the structure of the LT 
AB, holotoxin at 1.95 A resolution [1,2]. The LT A 
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subunit consists in the holotoxin of a single peptide chain 
containing 240 residues [3,4]. Its tertiary structure clearly 
consists of two domains (Fig. 1). The bulk of the subunit 
comprises the roughly conical A, domain containing an 
irregular a@ secondary structure. The smaller AZ do- 
main consists of a 23-residue a-helix near the carboxy- 
terminal extending from the A, domain to the flat base 
of the B, pentamer and terminating in an extended chain 
which spans the central pore of the B, pentamer and 
serves to link the A subunit to the B pentamer. Catalytic 
activity is located solely on the A, fragment [5]. For full 
activity the two domains must be separated by pro- 
teolytic cleavage of the main chain and also by reduction 
of the disulfide bond (CysA’*‘- C~SA’~~) linking A, and 
A2 [6-81. The short peptide chain linking the two do- 
mains (approximately residues 183-196) is only partially 
visible in the X-ray structure of the intact holotoxin, and 
is presumed to be a flexible loop containing the prote- 
olytic cleavage site. In K cholerae an endoprotease is 
present which nicks the A subunit of CT to separate A, 
and A, [9]. In E. coli no such protease is present and the 
LT toxin is instead activated later by a protease in the 
host cell which cleaves somewhere between residues 192 
and 195. It is not entirely clear why the cleavage and 
reduction are required. Possible explanations include di- 
rect linkage of disulfide reduction with membrane 
translocation, a hypothetical requirement for the A, 
fragment to be separated from the rest of the toxin for 
efficient membrane translocation, exposure or increased 
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Fig. 1. Threediiensional representation of LT AB, structure (program 
MOLSCRIPT [22]). The two domains of the A subunit are clearly 
visible, with A, forming an inverted cone at the upper left of the figure, 
and A, comprising the long helical region whose tail extends through 
the central pore of the B pentamer. Sidechains of residues implicated 
as active site residues are shown in ball and stick representation, as is 
the disulfide bridge between residues Al87 and A199. The cleavage site 
is located at the juncture of the two domains, and is physically remote 
from the region of the A, domain tentatively identified as the active site. 
For clarity, the B subunits are depicted as a simplified backbone tracing 
so that the carboxy-terminus of the A subunit (RDEL signal sequence) 
is not obscured. 
accessibility of the substrate binding site, or a possible 
conformational change which promotes catalysis. The 
present report describes the crystallographically deter- 
mined structure at 2.6 A resolution of the LT AB, holo- 
toxin in which the peptide chain of the A subunit has 
been cleaved, but the linking disulfide bond has not been 
reduced. 
2. Experimental 
Purified heat-labile enterotoxin from porcine E. coli [lo] was con- 
centrated in TEA buffer (100 mM Tris, 1 mM EDTA, 0.02% sodium 
azide) and 0.2 M NaCl to a protein concentration f 17 mg/ml. Prote- 
olysis was conducted by incubating 125 ~1 of the protein solution at 
room temperature with 5 ~1 of trypsin at a concentration of 5 mg/ml. 
After 30 min proteolysis was stopped by addition of 5 ,~l of BPTI at 
a concentration of 3 mg/ml. To confirm that the A chain of the toxin 
had in fact been cleaved, the treated protein was run on SDS-PAGE 
in the presence of /3-mercaptoethanol (Fig. 2). Crystallization was car- 
ried out using a variant of the three-layer liquid-liquid diffusion proce- 
dure described in [lo]. Crystallographic data collection is summarized 
in Table 1. 
A starting crystallographic model for the protein chains was taken 
from the refined 1.95 A structure of the native LT AB, [2]. An initial 
round of refinement in which the five copies of the B subunit were 
treated as rigid bodies, and four regions of the A subunit chain were 
similarly treated, brought the crystallographic R factor to R = 0.26. 
Subsequent refinement of individual positional and isotropic thermal 
parameters for the protein atoms produced a value of R = 0.20. At this 
point the fit of the model protein chain to the observed electron density 
was evaluated and optimized in a series of (F,F,) electron density maps 
covering the entire toxin molecule. In each map approximately 50 
residues (-7% of the total structure) were omitted from the calculation 
of F,. A model for the discretely ordered solvent was constructed 
incrementally by identifying peaks from successive (F,FJ maps. Be- 
fore each incremental map calculation all proteins atoms and previ- 
ously identified solvent sites were refined. The Iinal solvent model 
contains 197 discretely ordered waters, each of which exhibited electron 
density at greater than 3a and acceptable hydrogen-bonding eometry. 
Continued refinement achieved a linal crystallographic R value of 0.172 
for a model including a small overall anisotropic B correction (Table 
1). All crystallographic refinement was carried out using X-PLOR 
version 2.1 [ll]. 
3. Results 
Electron density for residues 189-195 of the A subunit, 
within which the proteolytic cleavage site lies, was not 
visible in the original LT X-ray structure at 1.95 A reso- 
lution nor is it visible in the present structure of the 
cleaved toxin. This is consistent with the cleavage site 
lying on a flexible loop accessible to protease, but unfor- 
tunately does not permit us to inspect he actual cleavage 
site in the crystallographic model. Nevertheless, one 
might expect the cleavage to allow or induce conforma- 
tional changes or additional flexibility in neighboring 
regions of the structure. Such changes are not seen, how- 
ever, in the present structure. The overall RMS differ- 
ence in main-chain coordinates observed for the A sub- 
unit between the 1.95 A holotoxin structure and the pres- 
ent structure is only 0.21 A (Fig. 3A), compared with an 
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Fig. 2. SDS-polyacrylamide gel electrophoresis of LT prior to crystalli- 
zation. Lane 1, markers; lane 2, LT prior to trypsin cleavage; lane 3, 
LT + dithiothreitol; lane 4, LT after trypsin cleavage (crystalliiation 
condition); lane 5, LT after trypsin cleavage + dithiothreitol. Note that 
the gel is run in the presence of/3-mercaptoethanol, so that the disulfide 
bond linking A, and A, is reduced in all cases; i.e. the presence or 
absence of prior treatment with dithiothreitol is not distinguishable on 
this gel. 
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overall RMS difference of 0.27 A for all atoms in the six 
protein subunits. Although the largest difference is ob- 
served as expected for the residues immediately adjacent 
to the flexible loop (188A, 196A-198A), this shift does 
not propagate to residues which are nearby either spa- 
tially or sequentially. The largest remaining differences 
between the two sets of coordinates for the A subunit are 
seen in the regions A32-A37 and A75A80. Since these 
are also the residues with the highest hermal parameters 
in both structures, the larger difference in refined coordi- 
nates is most likely due purely to intrinsic uncertainty in 
the models due to thermal motion in these regions. The 
orientation of the A, or A, fragments relative to each 
other or to the B pentamer differs by less than 0.25” from 
what is seen in the uncleaved structure. 
The average thermal parameter B for all protein atoms 
in the present 2.6 A model of the cleaved structure is 19.3 
A’ (B, = 23.7 A2 for the A subunit, Bavg = 17.4 A2 for 
the B pentamer). This is somewhat lower than that found 
for the 1.95 A model for the uncleaved structure (Fig. 
3B), but is consistent with other LT data sets we have 
refined ([2,12], also unpublished results). It may never- 
theless be worth noting that the B values for the main- 
chain atoms immediately adjacent o the cleavage site are 
relatively lower in the present cleaved structure than they 
were in the original uncleaved structure. 
Table 1 
Crystallographic data for partially activated LT 
Data used in 
refinement: 
Model: 
Crystallographic R: 
Stereochemistry: 
21320 reflections 10 A-2.6 A, no cut-off on Z/u(Z) 
6175 atoms contributing to F, 
197 water molecules in solvent model 
0.173 with no overall B correction 
0.172 with overall anisotropic B correction: 
B,, = 0.01573 Bu = -0.03028 B,, = 0.02301 
Blz = 0.00763 B,, = 0.01256 B,, = -0.00713 
0.015 A RMS deviation from ideal bond lengths 
3.24” RMS deviation from ideal bond angles 
Crystallization of the trypsin-nicked enterotoxin was performed using 
liquid-liquid diffusion in glass capillaries. Successive layers consisting 
of 5 ~1 of protein solution after proteolysis as described above, 10 ~1 
of 50 mM fructose in TEA, and 5 ,ul of 6% PEG 6000 in TEA were 
applied on top of each other in glass capillaries. The middle layer 
contained a non-binding sugar (fructose) to slow down nucleation of 
the crystals. During two weeks of storage at room temperature crystals 
formed in space group P2,2,2, with cell dimensions essentially identi- 
cal to crystals of the uncleaved AB, holotoxin (a = 119.2 A, b = 98.2 
A, c = 64.8 A, one ABS hexamer per a.s.u.). Crystallographic data 
were measured from a single crystal at room temperature using an 
Enraf-Nonius FAST area detector mounted on an Elliot G21 rotating 
anode. 47,662 observations from ~0 to 2.6 8, were processed with 
programs MADNES [23] and XDS [24] to give 21,707 unique reflec- 
tions to 2.6 A (90% complete, R,, = 0.086). 
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4. Discussion 
Many bacterial protein toxins are produced in a pro- 
enzyme form, and must be activated by subsequent proc- 
essing during secretion or during entry into the target 
cell. For LT and CT both proteolysis of the A subunit 
and reduction of the 187-l 99 disulfide bond are required 
for activation [6,7]. In determining the mechanistic sig- 
nificance of these activation steps it may be instructive 
to consider what is known of the activation process for 
other related toxins. Shiga toxin and shiga-like toxins are 
structurally similar to LT and CT in that they assemble 
as AB, assemblages, and their A subunits can be split 
into A, and A2 fragments of similar sizes by cleavage in 
a protease labile region. In vitro activation of shiga toxin 
requires nicking in the presence of DTT and SDS [ 13,141. 
The enzymatic activity of the shiga toxins is different 
from that of LT and CT, however, and there is no signif- 
icant sequence homology. Pseudomonas exotoxin and 
diphtheria toxin, on the other hand, catalyze the same 
ADP-ribosylating reaction as LT and have considerable 
functional similarity in the enzymatic domain, but have 
a very different subunit structure [1,15,16]. Both exo- 
toxin and diphtheria toxin are activated by cleavage and 
reduction of a disulfide loop, and the details are some- 
what better known than for the equivalent activation of 
LT. The catalytic C domain of diphtheria toxin is con- 
nected to the remainder of the protein by a flexible loop 
anchored at the base by an inter-domain disulfide bridge 
between residues 186 and 200 [16]. This loop must be 
cleaved for activation, but the precise nature of the cleav- 
age site is unimportant [ 171. For diphtheria toxin reduc- 
tion of the disulfide bond is the rate-limiting step in 
intoxication, and occurs prior to or coincident with 
translocation from an endosomal compartment o the 
cytoplasm [18,191. Exotoxin A is cleaved between Arg27p 
and Glf*’ by an intracellular protease [15], and is simi- 
larly reduced in an endosomal compartment prior to or 
coincident with translocation [20]. 
Thus there are a number of bacterial toxins which 
require a proteolytic cleavage of a flexible region irre- 
spective of enzymatic activity or subunit structure, and 
certainly without identifiable sequence homology. Even 
between LT and CT there are 6 sequence differences in 
the loop from 183-196 [4], substantially less homology 
than is present between the sequences as a whole. Thus 
a flexible region needed for toxin activation is a con- 
served feature but the actual cleavage site is not very 
important. In the course of evolution many rearrange- 
ments of subunit structures have occurred in these multi- 
subunit toxins. Why then do these toxins conserve such 
a proteolytic site rather than splitting into separate sub- 
units? A plausible model is that the A, fragment holds 
structural features necessary for internalization of the 
toxin or proper targeting to the cellular compartment 
where the toxin acts. A close association of A, and A, 
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Rms difference in coordinates for A subunit of cleaved and uncleaved LT 
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Fig. 3. (A) RMS difference in coordinates (A) for the A subunit between the crystallographic models for the cleaved (present communication) and 
uncleaved [2] structures. Solid line = main-chain atoms; individual points = sidechain atoms. (B) Average thermal parameters B (A’) for mainchain 
atoms in the A subunit of the LT AB, holotoxin in the cleaved (present communication) and uncleaved [2] forms. 
is then required to bring the enzymatically active A, to 
its site of action. Following the model of diphtheria 
toxin, the reduction of the disulfide (or, more specula- 
tively, a recognition event involving the dangling ends of 
the flexible region subsequent o cleavage) is coincident 
with the final stage(s) of the intracellular transport proc- 
ess, after which the presence of the A, fragment is super- 
fluous. In this context it is also notable that the C-termi- 
nal sequence of the A, domain in LT is RDEL, known 
to be a signal sequence in eukaryotic cells which causes 
targeting of the protein to the endoplasmic reticulum 
(review, see [21]). How this signal sequence might func- 
tion in targeting a protein entering the cell from the 
outside remains to be explored. Finally, Moss et al. [8] 
have shown that both reduction and cleavage are re- 
quired for the toxin to bind the ADP-ribosylation factor 
(ARF) protein. While the location of the ARF binding 
site on the toxin is not known, this result suggests that 
it may lie on the surface of the Ai fragment which is 
obscured by the presence of A, prior to reduction and 
cleavage. 
The lack of any substantial conformational difference 
between the cleaved and uncleaved structures implies 
that cleavage of the peptide chain does not play a pri- 
mary role in the biological activation of the toxin. Since 
the disulfide bond between residues Al87 and Al99 
closely brackets the cleavage site it is likely that even 
after cleavage the peptide chains are held in their original 
conformation by the disulfide bridge. Only upon reduc- 
tion of this disulfide would a conformational change in 
the A, fragment, if any, take place. We are presently 
exploring the feasibility of further structural studies of 
the toxin after reduction. 
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